AstraZeneca PLC (AZN)

AZN (NYSE:Drugs) EQUITY
$32.07
pos +0.39
+1.20%
Today's Range: 32.12 - 32.66 | AZN Avg Daily Volume: 2,502,400
Last Update: 09/03/15 - 3:39 PM EDT
Volume: 1,897,453
YTD Performance: -9.97%
Open: $32.50
Previous Close: $31.68
52 Week Range: $29.50 - $37.97
Oustanding Shares: 2,528,000,000
Market Cap: 77,584,320,000
6-Month Chart
TheStreet Ratings Grade for AZN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.33 2.33 2.33 2.33
Latest Dividend: 0.44
Latest Dividend Yield: 4.50%
Dividend Ex-Date: 08/12/15
Price Earnings Ratio: 30.09
Price Earnings Comparisons:
AZN Sector Avg. S&P 500
30.09 65.80 24.17
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.43% -15.11% 35.41%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.50 -0.22 -0.08
Net Income -52.00 -0.88 -0.50
EPS -52.10 -0.87 -0.49
Earnings for AZN:
EBITDA 4.63B
Revenue 26.10B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.50 $0.43 $2.13 $2.01
Number of Analysts 2 1 5 5
High Estimate $0.54 $0.43 $2.18 $2.11
Low Estimate $0.46 $0.43 $2.10 $1.85
Prior Year $0.52 $0.38 $2.14 $2.13
Growth Rate (Year over Year) -4.76% 13.16% -0.47% -5.45%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Key collaboration deals with deeper-pocketed concerns can improve the odds of investment success.
A look at the high-priced and weak among the most expensive sectors.
This small-cap biotech firm could be in the early stages of a big move.
And four other things you need to know now.
It's almost impossible to get too excited about its success.
That this could be such an open secret is beyond me.
New companies are coming up with major drugs.
Two are biotechs and one is in cyber security.
And four other things you need to know now.
Combined Heinz-Kraft heads a long second-quarter list.

Columnist Conversations

And QQQ -$0.45
I have shorted today's ramp into tomorrow's #. See next post.
So far, the current upmove in the Emini S&P 500 has peaked at 1973.50, which is in the vicinity of the pri...
out of these for now as we saw no followthrough on tues. SOLD SPY 195 PUT AT 2.70 (IN AT 5.40) SOLD DIA SEPT 1...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.